跳至主要内容
临床试验/NCT04094467
NCT04094467Unknown4 期

CLASSICAL ANTAGONIST PROTOCOL IN COMPARISON WITH AGONIST STOP PROTOCOL IN Polycystic Ovary Symdrome WOMEN UNDERGOING Intra-cytoplasmic Injection TRIAL: a Randomized Controlled Trial

Assiut University1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2019年12月7日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
150
试验地点
1
主要终点
The difference in clinical pregnancy rate in both groups

研究概览

简要总结

Stein and Leventhal were the first to recognize an association between the presence of polycystic ovaries and signs of hirsutism and amenorrhea (eg,oligomenorrhea, obesity), After women diagnosed with Stein-Leventhal syndrome underwent successful wedge resection of the ovaries, their menstrual cycles became regular, and they were able to conceive. As a consequence, a primary ovarian defect was thought to be the main culprit, and the disorder came to be known as polycystic ovarian disease.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Women under 35 years with polycystic ovary syndrome criteria
  • Normal male semen parameters
  • Normal tubes either by hysterosalpingography &/or laparoscopy
  • Free from other endocrine abnormalities

排除标准

  • NON polycystic ovary syndrome Criteria
  • More than 35 years
  • Abnormal semen parameters
  • Pathological tube& pelvic factor
  • Other endocrine disorders

研究组 & 干预措施

Study group

Experimental

the antagonist protocol group" where they will do intra-cytoplasmic injection using classical antagonist protocol

干预措施: Cetrorelix (Drug)

control group

Active Comparator

"agonist stop/antagonist protocol group" where they will receive mid luteal agonist in the preceding intra-cytoplasmic injection cycle before starting classical antagonist protocol

干预措施: Cetrorelix (Drug)

control group

Active Comparator

"agonist stop/antagonist protocol group" where they will receive mid luteal agonist in the preceding intra-cytoplasmic injection cycle before starting classical antagonist protocol

干预措施: Leuprolide Acetate (Drug)

结局指标

主要结局

The difference in clinical pregnancy rate in both groups

时间窗: 6 weeks

ultrasound detection of fetal heart pulsations

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmed Mohamed Abbas

Principal investigator

Assiut University

研究点 (1)

Loading locations...

相似试验